Measurement and Evaluations in Cancer Care Medicine

Measurement challenges in immuno-oncology and novel therapies: Harmonising Toxicity and Response Assessment Across Immune Checkpoint Inhibitors, CAR-T, bispecific antibodies, and radioligand therapies

Elsevier ·

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →